Glycerolipid Analysis. LC/MS/MS Analytical Services

Similar documents
Phospholipid Analysis. P NMR Analytical Services

SUPPLEMENTARY DATA. Materials and Methods

The use of mass spectrometry in lipidomics. Outlines

Impact of Chromatography on Lipid Profiling of Liver Tissue Extracts

Mass Spectrometry based metabolomics

Mass-Spectrometric Analysis of Lipids (Lipidomics)

A Definitive Lipidomics Workflow for Human Plasma Utilizing Off-line Enrichment and Class Specific Separation of Phospholipids

Supporting information

Increased Identification Coverage and Throughput for Complex Lipidomes

LC/MS/MS SOLUTIONS FOR LIPIDOMICS. Biomarker and Omics Solutions FOR DISCOVERY AND TARGETED LIPIDOMICS

Essential Lipidomics Experiments using the LTQ Orbitrap Hybrid Mass Spectrometer

Comprehensive Two-Dimensional HPLC and Informative Data Processing for Pharmaceuticals and Lipids

Comprehensive Lipidome Analysis by Shotgun Lipidomics on a Hybrid Quadrupole-Orbitrap-Linear Ion Trap Mass Spectrometer

Supporting information

Lipid Analysis. Andréina Laffargue, IRD CRYMCEPT Montpellier workshop, October 17th Introduction to lipid structures

What You Can t See Can Hurt You. How MS/MS Specificity Can Bite Your Backside

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

Thermo Scientific LipidSearch Software for Lipidomics Workflows. Automated Identification and Relative. Quantitation of Lipids by LC/MS

Improved method for the quantification of lysophospholipids including enol ether

Organic Chemistry Laboratory Fall Lecture 3 Gas Chromatography and Mass Spectrometry June

Principles of Shotgun Lipidomics

Supporting Information

Relative Quantitation of Human Polymorphonuclear Leukocyte Cell Membrane GPEtn Lipids

Achieve Broad Lipid Quantitation using a High-Throughput Targeted Lipidomics Method

Lipids Analysis. Lipids

Agilent Solutions for Lipidomics. Greater Insight into

Lipid Class Separation Using UPC 2 /MS

Measuring Lipid Composition LC-MS/MS

Analysis of Phospholipids in Natural Samples by Normal Phase HPLC and Corona Charged Aerosol Detection

LOCALISATION, IDENTIFICATION AND SEPARATION OF MOLECULES. Gilles Frache Materials Characterization Day October 14 th 2016

Core E Analysis of Neutral Lipids from Human Plasma June 4, 2010 Thomas J. Leiker and Robert M. Barkley

Rapid Lipid Profiling of Serum by Reverse Phase UPLC-Tandem Quadrupole MS

The HPLC Preparative Scale-Up of Soybean Phospholipids Application

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

1. Methodology of lipidomics: Tandem mass spectrometry of ether phospholipids

Chromatography Vacuum Ultraviolet Spectroscopy

Poly-unsaturated phospholipids WE (FA18:1) A B C D OAHFA 18:1/24:0 OAHFA 18:1/30:2 PS 38:4 C18:1C23:0 OAHFA 18:1/25:0 OAHFA 18:1/30:1

Advancing your Forensic Toxicology Analyses; Adopting the Latest in Mass Spectrometry Innovations

Characterization of an Unknown Compound Using the LTQ Orbitrap

Ultra Performance Liquid Chromatography Coupled to Orthogonal Quadrupole TOF MS(MS) for Metabolite Identification

The Comparison of High Resolution MS with Triple Quadrupole MS for the Analysis of Oligonucleotides

Choosing the metabolomics platform

Accurate Quantification of Lipid Species by Electrospray Ionization Mass Spectrometry Meets a Key Challenge in Lipidomics

1. Sample Introduction to MS Systems:

New Mass Spectrometry Tools to Transform Metabolomics and Lipidomics

Supplemental Information. LipiDex: An Integrated Software Package. for High-Confidence Lipid Identification

Enrichment of Phospholipids from Biological Matrices with Zirconium Oxide-Modified Silica Sorbents

Metabolite identification in metabolomics: Database and interpretation of MSMS spectra

The detergent-solubilized and gel filtration purified rhodopsin was partitioned against

High-throughput lipidomic analysis of fatty acid derived eicosanoids and N-acylethanolamines

Identification & Confirmation of Structurally Related Degradation Products of Simvastatin

Determination of N-Nitrososarcosine (NSAR) in tobacco

LC/MS Method for Comprehensive Analysis of Plasma Lipids

New Frontiers for MS in Metabolipidomics

PosterREPRINT RAPID, SELECTIVE SCREENING OF URINE SAMPLES FOR GLUCURONIDES BY LC/MS/MS INTRODUCTION ABSTRACT

SelexION Technology for Lipid Analysis: Pushing the Boundaries of Lipidomics

MASS SPECTROMETRY BASED METABOLOMICS. Pavel Aronov. ABRF2010 Metabolomics Research Group March 21, 2010

Metabolomics: quantifying the phenotype

Quantification of PtdInsP 3 molecular species in cells and tissues by mass spectrometry

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

Application Note # LCMS-89 High quantification efficiency in plasma targeted proteomics with a full-capability discovery Q-TOF platform

methods Electrospray mass spectrometry of human hair wax esters Mark Fitzgerald and Robert C. Murphy 1

LC-MS Analysis of Botanicals

Received: 21 September 2009 / Revised: 2 November 2009 / Accepted: 3 November 2009 / Published online: 25 November 2009 # Springer-Verlag 2009

Improving Selectivity in Quantitative Analysis Using MS 3 on a Hybrid Quadrupole-Linear Ion Trap Mass Spectrometer

Benefits and Characteristic Applications of High Resolution GC/MS and LC/MS. Frank David RIC and Ghent University

Metabolite identification in metabolomics: Metlin Database and interpretation of MSMS spectra

Moving from targeted towards non-targeted approaches

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

CEU MASS MEDIATOR USER'S MANUAL Version 2.0, 31 st July 2017

Simple and Robust Measurement of Blood Plasma Lysophospholipids Using Liquid Chromatography Mass Spectrometry

MALDI-TOF. Introduction. Schematic and Theory of MALDI

Comprehensive Forensic Toxicology Screening in Serum using On-Line SPE LC-MS/MS

SUPPORTING INFORMATION. Nontargeted quantitation of lipid classes using hydrophilic interaction liquid

Polymer Additive Analysis by EI and APCI

Identification of Steroids in Water by Ion Trap LC/MS/MS Application

Life Science and Chemical Analysis Solutions. Baljit Ubhi, Jeff Patrick, David Alonso, and Joe Shambaugh 1 2 3

Phospholipid characterization by a TQ-MS data based identification scheme

Improving Coverage of the Plasma Lipidome Using Iterative MS/MS Data Acquisition Combined with Lipid Annotator Software and 6546 LC/Q-TOF

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

MS/MS Scan Modes. Eötvös University, Budapest April 16, MS/MS Scan Modes. Árpád Somogyi. Product Ion Scan Select. Scan. Precursor Ion Scan Scan

Application Note # MT-94 Direct Read-out of Thin Layer Chromatography (TLC) using MALDI-TOF

SWATH Acquisition Enables the Ultra-Fast and Accurate Determination of Novel Synthetic Opioids

Methods in Mass Spectrometry. Dr. Noam Tal Laboratory of Mass Spectrometry School of Chemistry, Tel Aviv University

4.5 Minute Analysis of Benzodiazepines in Urine and Whole Blood Using LC/MS/MS and an Ultra Biphenyl Column

Lipid Analysis ISOLATION, SEPARATION, IDENTIFICATION AND. Bridgwater, England LIPIDOMIC ANALYSIS. Fourth Edition. Invergowrie, Dundee, Scotland

Vitamins and Food Contaminants by UPLC/MS/MS

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

2. Ionization Sources 3. Mass Analyzers 4. Tandem Mass Spectrometry

LC-Based Lipidomics Analysis on QTRAP Instruments

Analysis and Quantitation of Cocaine on Currency Using GC-MS/MS. No. GCMS No. SSI-GCMS-1501

Ion fragmentation of small molecules in mass spectrometry

Impurity Identification using a Quadrupole - Time of Flight Mass Spectrometer QTOF

Obtaining Answers to Biological Questions Sample Prep to Data Analysis. Jeremiah D. Tipton, Ph.D. SCIEX Advanced Workflow Specialist in OMICS

Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ

Identification and Quantitation of Microcystins by Targeted Full-Scan LC-MS/MS

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

NIH Public Access Author Manuscript J Proteome Res. Author manuscript; available in PMC 2014 July 05.

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine

Transcription:

Glycerolipid Analysis LC/MS/MS Analytical Services

Molecular Characterization and Quantitation of Glycerophospholipids in Commercial Lecithins by High Performance Liquid Chromatography with Mass Spectrometric Detection Jeff D. Moore, Katherine L. Lanier and Walter A. Shaw October, 2008 Avanti Polar Lipids, Inc. Alabaster, AL. 35007 Introduction: Lecithin is a loosely defined material that contains predominately neutral lipids and glycerophospholipids (GPLs) extracted from natural products such as soybean, algae and marine sources. The glycerophospholipids contained therein have beneficial pharmacologic and nutritional properties. Lecithin or modified lecithin products administered alone or in combination with drugs are used as emulsifiers, drug carriers, nutritional supplements and active nutraceuticals. The number and molecular diversity of GPL structures present within lecithins are quite large and dependant on their source. Molecular characterization and content of the GPLs is becoming a prerequisite for their use according the current good manufacturing practices (cgmps) employed in the pharmaceutical and nutraceutical industries. Avanti Polar Lipids Analytical Services utilizes high performance liquid chromatography (HPLC) with a hybrid triple quadrapole - linear ion trap mass spectrometry (MS/MS-LIT) to characterize the molecular structures and quantify their respective content of the major GPLs in lecithins. This methodology circumvents classical approaches of thin-layer chromatography or HPLC fractionation of GPL groups followed by gas chromatography for fatty acid composition and or reversed phase separation for molecular species against (non)-available standards. Principle: A mass spectrometric detector provides an additional dimension to separation and quantitation of complex samples when utilized in conjunction with high performance liquid chromatography. Rather than identity and measurement of a compound based on retention time and peak response of a molecularly identical standard, mass spectrometry allows for identification based on the molecular weight of the compound(s) and quantitation using internal standards of similar structure. Full resolution of all compounds in a sample is not required due to the added third dimension of unique molecular weights for individual analytes. Further collisional dissociation of these specific molecular ions provides additional structural specificity as well as confirmation of analyte structure. Initially, a lecithin matrix must be characterized for the major GPL groups and respective molecular species of which it is comprised. This is performed by using the MS/MS to scan specifically for molecules within a GPL group to the exclusion of all others. For example, phosphatidylserines (PS) 2

undergo a neutral loss of 87 daltons (u) from their de-protonated exact mass ([M-H]-) when assayed in negative ionization mode under instrument conditions which induce collisional dissociation (CID), i.e. fragmentation. This molecular MS/MS reaction can be utilized to detect all the PS molecular species by performing a neutral loss scan for -87 u. The mass spectrometer returns a spectrum of masses equivalent to the [M-H]- for each PS species detected. These masses can be interpreted to a presumptive structure using a molecular weight library for GPLs. The presumptive identity is assigned by total number of acyl carbons and double bonds within the molecule (CC:DB), such as 36:4 PS. This 36:4 PS designation however could be equivalent to 5 different molecules to include 14:0-22:4 PS, 16:0-20:4 PS, 16:1-20:3 PS, 18:1-18:3 PS and 18:2-18:2 PS, positional ions withstanding. Secondly, the identified PS, [M-H]- masses and their corresponding [M-87]- u fragmentation reactions are optimized within the MS/MS quadrapoles. This provides for very sensitive and selective analysis of each PS species. This technique is known as multiple reaction monitoring (MRM). This MRM profile for PS species coupled with in-time separation afforded by reversed phase HPLC allows for possible quantitation without isotope correction between M+2 isotopes and CC:DB+1 molecular species. The measurement of each PS species is calculated from the linear area / concentration response of internal standards spiked into the lecithin sample prior to injection. These internal standards are synthetic GPLs which are exogenous in nature and have a defined concentration and stability. Thirdly, a collision mass spectrum is generated by coupling the HPLC/MS/MS with the LIT of the hybrid instrument. As the PS peaks elute from the HPLC column their corresponding MRM peak is detected by the MS/MS. Resultant peaks of a minimum preset intensity triggers the LIT to collect a spectrum designed to deliver the molecular fragmentation of the peak. Interpretation of this spectrum allows for assignment of the final molecular species. The technique described above can be performed for phosphatidylcholine (PC), phosphatidylinositol (PI) and phosphatidylethanolamine (PE) species as well as PS based on their respective and specific mass spectral fragmentation properties. Unfortunately, phosphatidic acid and phosphatidylglycerol do not have group specific fragmentation mechanisms which are conducive to the present method conditions. These two GPL groups were not measured for this reason. Avanti Polar Lipids Analytical Services LC/MS/MS method for GPLs uses these advantageous fragmentation mechanisms to measure the individual compounds for PC, PE, PI and PS and there lyso counterparts (LPC, LPE, LPI and LPS) within a lecithin sample on a weight percentage basis. This document will report the molecular characterization and quantitation of major GPLs in crude soy lecithin and PS modified soy lecithin samples. Figure 1 demonstrates the HPLC/MS/MS-LIT technique described above for an aged PS modified soy lecithin. Tables 1 and 2 report the detected GPLs in crude soy lecithin and a PS modified soy lecithin sample different than that demonstrated in figure 1. Table 3 reports comparison of assay of total GPL groups between LC/MS/MS and 31P-NMR performed by Avanti Polar Lipids. 3

Figure 1: Detection of PS molecular species in aged PS modified soy lecithin. HPLC/MRM chromatogram demonstrates resolution of molecular species. Peaks at 0.9, 3-6.5 and 6.5-10 minutes are LPS, oxidized PS and PS species respectively. Major MRM of 7.7 min peak is 782.5 / 695.5 (M-H-87) u for 36:4 PS. Extracted ion chromatogram of 782.5 / 695.5 u. Note the separation of the [M+2] isotope peak of 36:3 PS (784.5/697.5 u) at 6.89 min. 4 LIT spectrum of 782.5 / 695.5 peak at 7.3 8.0 min. 782.3 u = [M-H]-, 695.4 u = [M-H-87]-, 433.0 u = [695.4 C18H30O]-, 415.1 u = [695.4 C18H32O2]-, 279.1 u = [M-H]- of 18:2 acid. Minor peaks of 277.1 (18:3) and 281.0 (18:1) u are detectable (not shown). Interpretation: 36:4 PS is predominately 18:2-18:2 PS with minor amounts of 18:1-18:3 PS.

Table 1: Glycerophospholipid Profile of Crude Soy Lecithin GPL (CC:DB) Analyte Retention Time (min) Analyte Mass Ranges (amu) Structure from LIT Spectrum %/W %Rsd of Triplicate Assay % of GPL / Group Phosphatidylcholines 18:2 LPC 1.5 578.3/504.2 amu 18:2 LPC 1.58 3.84 9.20 17:1 LPC ISTD 1.5 566.4/492.4 amu 17:1 LPC 16:0 LPC 1.7 554.3/480.2 amu 16:0 LPC 0.52 9.35 3.04 18:1 LPC 1.9 580.4/506.3 amu 18:1 LPC 0.31 14.72 1.80 25:0 PC ISTD 6.4 694.5/620.4 amu 12:0-13:0 PC 31:1 PC ISTD 10.0 776.5/702.4 amu 17:0-14:1 PC 36:4 PC 10.5 840.6/766.5 amu 18:2-18:2 PC 0.35 4.97 2.03 34:2 PC 10.9 816.6/742.5 amu 16:0-18:2 PC 5.63 3.32 32.82 36:3 PC 11.2 842.6/768.5 amu 18:1-18:2 PC 3.91 6.13 22.80 32:0 PC 11.3 792.6/718.5 amu 16:0-16:0 PC 0.62 8.82 3.62 34:0 PC 11.7 820.6/746.5 amu 16:0-18:0 PC 0.15 16.16 0.85 34:1 PC 11.7 818.6/744.5 amu 16:0-18:1 PC 1.77 3.65 10.28 37:4 PC ISTD 11.4 854.6/780.5 amu 17:0-20:4 PC 38:4 PC 11.5 868.6/794.5 amu 18:0-20:4 PC 0.02 11.54 0.12 36:2 PC 12.0 844.6/770.5 amu 18:1-18:1 PC 1.97 9.70 11.47 36:1 PC 12.7 846.6/772.5 amu 18:0-18:1 PC 0.20 10.75 1.18 43:6 PC ISTD 13.2 934.7/860.6 amu 21:0-22:6 PC 36:0 PC 13.4 848.6/774.5 amu 18:0-18:0 PC 0.13 45.99 0.77 Phosphatidylethanolamines 16:0 LPE 1.4 454.3/313.2 amu 16:0 LPE 0.44 7.9 3.26 17:1 LPE ISTD 1.3 466.6/325.5 amu 17:1 LPE 18:2 LPE 1.3 478.3/337.2 amu 18:2 LPE 1.20 4.0 8.83 25:0 PE ISTD 5.9 594.4/453.4 amu 12:0-13:0 PE 36:4 LPE 9.3 738.5/597.5 amu 18:2-18:2 PE 0.40 6.1 2.93 36e_0 PE 9.3 760.6/619.6 amu 18:0e-18:0 PE 0.01 19.9 0.10 31:1 PE ISTD 9.5 676.5/535.5 amu 17:0-14:1 PE 34:2 PE 9.7 714.5/573.5 amu 16:0-18:2 PE 0.39 3.5 2.89 36:3 PE 10.0 740.5/599.5 amu 18:1-18:2 PE 0.71 2.2 5.23 34:1 PE 10.4 716.5/575.6 amu 16:0-18:1 PE 6.57 5.5 48.29 36:2 PE 10.8 742.5/601.5 amu 18:1-18:1 PE 2.61 2.9 19.18 34e:2 PE 11.0 730.5/589.4 amu 16:0e-18:2 PE 0.02 5.6 0.13 37:4 PE ISTD 11.0 754.5/613.5 amu 17:0-20:4 PE 34:0 PE 11.2 718.5/577.5 amu 16:0-18:0 PE 0.24 9.1 1.79 36:1 PE 11.5 744.5/603.5 amu 18:8-18:1 PE 0.91 4.0 6.66 36:0 PE 12.2 746.5/605.5 amu 18:0-18:0 PE 0.10 7.8 0.72 43:6 PE ISTD 12.8 834.6/693.6 amu 21:0-22:6 PE 5

Table 1 (cont): Glycerophospholipid Profile of Crude Soy Lecithin GPL (CC:DB) Analyte Retention Time (min) Analyte Mass Ranges (amu) Structure from LIT Spectrum %/W %Rsd of Triplicate Assay % of GPL / Group Phosphatidylinositols 17:1 LPI ISTD 0.6 583.3/241.0 amu 17:1 LPI 18:2 LPI 0.6 595.3/241.0 amu 18:2 LPI 0.66 7.27 8.71 16:0 LPI 0.6 571.3/241.0 amu 16:0 LPI 0.67 22.56 8.84 18:1 LPI 0.7 597.3/241.0 amu 18:1 LPI 0.11 16.04 1.45 25:0 PI ISTD 1.9 711.4/241.0 amu 12:0-13:0 PI 36:5 LPI 4.8 855.5/241.0 amu 18:2-18:3 PI 0.19 11.91 2.51 31:1 PI ISTD 4.9 793.5/241.0 amu 17:0-14:1 PI 34:3 LPI 5.2 831.5/241.0 amu 16:0-18:3 PI 0.41 2.09 5.41 36:4 PI 5.6 857.5/241.0 amu 18:2-18:2 PI 0.98 17.40 12.93 34:2 PI 6.0 833.5/241.0 amu 16:0-18:2 PI 3.29 6.73 43.40 36:3 PI 6.5 859.5/241.0 amu 18:1-18:2 PI 0.59 15.96 7.78 37:4 PI ISTD 6.7 871.5/241.0 amu 17:0-20:4 PI 36:2 PI 7.3 861.5/241.0 amu 18:0-18:2 PI 0.63 5.59 8.31 36:1 PI 8.1 863.5/241.0 amu 18:0-18:1 PI 0.05 5.91 0.66 43:6 PI ISTD 9.1 951.6/241.0 amu 21:0-22:6 PI PC+PE+PI 38.35 %/W 6

Table 2: Glycerophospholipids in Phosphatidylserine Modified Soy Lecithin GPL (CC:DB) Analyte Retention Time (min) Analyte Mass Ranges (amu) Structure from LIT Spectrum %/W %Rsd of Triplicate assay % of GPL / Group Phosphatidylcholines 18:2 LPC 1.4 578.3/504.2 amu 18:2 LPC 1.95 2.14 15.62 17:1 LPC ISTD 1.6 566.4/492.4 amu 17:1 LPC 16:0 LPC 1.7 554.3/480.2 amu 16:0 LPC 0.56 4.87 4.47 18:1 LPC 2.0 580.4/506.3 amu 18:1 LPC 0.31 7.97 2.52 25:0 PC ISTD 6.5 694.5/620.4 amu 12:0-13:0 PC 31:1 PC ISTD 10.0 776.5/702.4 amu 17:0-14:1 PC 36:4 PC 10.5 840.6/766.5 amu 18:2-18:2 PC 0.32 7.07 2.53 34:2 PC 10.9 816.6/742.5 amu 16:0-18:2 PC 3.96 14.76 31.78 36:3 PC 11.3 842.6/768.5 amu 18:1-18:2 PC 2.37 5.92 19.00 32:0 PC 11.4 792.6/718.5 amu 16:0-16:0 PC 0.42 15.47 3.35 34:0 PC 11.7 820.6/746.5 amu 16:0-18:0 PC 0.06 2.28 0.46 34:1 PC 11.7 818.6/744.5 amu 16:0-18:1 PC 0.64 35.21 5.11 37:4 PC ISTD 11.4 854.6/780.5 amu 21:0-22:6 PC 38:4 PC 11.6 868.6/794.5 amu 18:0-20:4 PC 0.02 27.61 0.18 36:2 PC 12.0 844.6/770.5 amu 18:0-18:2 PC 1.54 8.24 12.33 36:1 PC 12.7 846.6/772.5 amu 18:0-18:1 PC 0.12 8.25 0.98 43:6 PC ISTD 13.3 934.7/860.6 amu 36:0 PC 13.4 848.6/774.5 amu 18:0-18:0 PC 0.21 17.75 1.67 Phosphatidylethanolamines 16:0 LPE 1.6 454.3/313.2 amu 16:0 LPE 0.40 5.08 3.52 17:1 LPE ISTD 1.4 466.6/325.5 amu 17:1 LPE 18:2 LPE 1.4 478.3/337.2 amu 18:2 LPE 1.27 3.90 11.10 25:0 PE ISTD 6.0 594.4/453.4 amu 12:0-13:0 PE 36:4 LPE 9.3 738.5/597.5 amu 18:2-18:2 PE 0.59 3.38 5.14 36e:0 PE 9.3 760.6/619.6 amu 18:0e-18:0 PE 0.02 15.45 0.21 31:1 PE ISTD 9.5 676.5/535.5 amu 17:0-14:1 PE 34:2 PE 9.8 714.5/573.5 amu 16:0-18:2 PE 0.47 1.44 4.12 36:3 PE 10.1 740.5/599.5 amu 18:1-18:2 PE 0.75 3.35 6.60 34:1 PE 10.5 716.5/575.6 amu 16:0-18:1 PE 5.10 0.38 44.65 36:2 PE 10.8 742.5/601.5 amu 18:1-18:1 PE 1.77 4.97 15.52 34e:2 PE 11.0 730.5/589.4 amu 16:0e-18:2 PE 0.01 16.99 0.10 37:4 PE ISTD 11.0 754.5/613.5 amu 17:0-20:4 PE 34:0 PE 11.2 718.5/577.5 amu 16:0-18:0 PE 0.10 2.69 0.89 36:1 PE 11.6 744.5/603.5 amu 18:0-18:1 PE 0.87 6.49 7.63 36:0 PE 12.2 746.5/605.5 amu 18:0-18:0 PE 0.06 5.95 0.52 43:6 PE ISTD 12.8 834.6/693.6 amu 21:0-22:6 PI 7

Table 2 (cont): Glycerophospholipids in Phosphatidylserine Modified Soy Lecithin GPL (CC:DB) Analyte Retention Time (min) Analyte Mass Ranges (amu) Structure from LIT Spectrum %/W %Rsd of Triplicate assay % of GPL / Group Phosphatidylinositols 16:0 LPI 0.7 571.3/241.0 amu 16:0 LPI 0.52 26.36 8.12 18:2 LPI 0.6 595.3/241.0 amu 18:2 LPI 0.52 15.09 8.20 17:1 LPI ISTD 0.7 583.3/241.0 amu 17:1 LPI 18:1 LPI 0.7 597.3/241.0 amu 18:1 LPI 0.07 3.98 1.04 25:0 PI ISTD 2.0 711.4/241.0 amu 12:0-13:0 PI 36:5 PI 4.8 855.5/241.0 amu 18:2-18:3 PI 0.22 11.12 3.40 31:1 PI ISTD 5.0 793.5/241.0 amu 17:0-14:1 PI 34:3 PI 5.3 831.5/241.0 amu 16:0-18:3 PI 0.51 10.54 7.97 36:4 PI 5.7 857.5/241.0 amu 18:2-18:2 PI 0.88 11.72 13.85 34:2 PI 6.1 833.5/241.0 amu 16:0-18:2 PI 2.58 4.56 40.49 36:3 PI 6.5 859.5/241.0 amu 18:1-18:2 PI 0.46 15.45 7.23 37:4 PI ISTD 6.8 871.5/241.0 amu 17:0-20:4 PI 36:2 PI 7.4 861.5/241.0 amu 18:0-18:2 PI 0.56 16.30 8.83 36:1 PI 8.2 863.5/241.0 amu 18:0-18:1 PI 0.06 25.12 0.88 43:6 PI ISTD 9.1 951.6/241.0 amu 21:0-22:6 PI Phosphatidylserines 18:3 LPS 0.6 518.3/431.3 amu 18:3 LPS 0.03 8.85 0.09 18:2 LPS 0.7 520.2/432.2 amu 18:2 LPS 0.28 10.86 0.80 17:1 LPS ISTD 0.7 508.3/421.3 amu 17:1 LPS 25:0 PS ISTD 1.4 636.4/549.4 amu 12:0-13:0 PS 36:6 PS 2.2 778.5/691.5 amu 18:3-18:3 PS 0.18 28.30 0.51 32:2 PS 2.6 730.5/643.5 amu 14:0-18:2 PS 0.06 8.60 0.18 36:5 PS 2.6 780.5/693.5 amu 18:2-18:3 PS 2.36 13.11 6.71 31:1 PS ISTD 2.8 718.6/631.6 amu 17:0-14:1 PS 34:3 PS 2.9 756.5/669.5 amu 16:0-18:3 PS 0.80 13.00 2.28 36:4 PS 3.1 782.5/695.5 amu 18:2-18:2 PS 13.03 6.08 36.99 34:2 PS 3.5 758.5/671.5 amu 16:0-18:2 PS 8.75 8.31 24.84 36:3 PS 3.8 784.5/697.5 amu 18:1-18:2 PS 5.73 3.34 16.25 37:4 PS ISTD 4.0 796.5/709.5 amu 17:0-20:4 PS 34:1 PS 4.2 760.5/673.5 amu 16:0-18:1 PS 1.61 23.66 4.56 34:0 PS 4.5 762.5/675.5 amu 16:0-18:1 PS 0.13 12.11 0.36 36:2 PS 4.7 786.5/699.5 amu 18:1-18:1 PS 2.27 17.55 6.44 43:7 PS ISTD 6.8 876.6/789.6 amu PC+PE+PI+PS 65.49 %/W 8

Crude Soy Lecithin Table 3: Comparison of Total GPLs by LC/MS/MS versus 31 P-NMR 31 P-NMR %/W LC/MS/MS %/W Diff PC 12.1 PC 14.8 2.7 LPC 2 LPC 2.4 0.4 PE 10.5 PE 11.6 1.1 LPE 2.6 LPE 2 0.6 PI 7.1 PI 6.1 1 LPI ND LPI 1.4 NA PS ND PS ND --- LPS ND LPS ND --- PS Modified Soy Lecithin 31 P-NMR %/W LC/MS/MS %/W Diff PC 11.9 PC 9.7 2.2 LPC 3.1 LPC 2.8 0.3 PE 10.6 PE 9.6 1 LPE 1.9 LPE 1.6 0.3 PI 7.3 PI 5.3 2 LPI NA LPI 1.1 NA PS 31.6 PS 34.9 3.3 LPS 0.6 LPS 0.3 0.3 ND = none detected, NA = not available due to same ppm shift as PE. Discussion: The methodology and data reported represent the characterization and content assay of PC, PE, PI and PS in two commonly available, commercial lecithins processed from soybean. The data reported in tables 1 and 2 as % weight of total sample provides content of individual GPLs and normalized % of each relative to GPL group total. The variance of triplicate assays was not more than ~15% for GPLs of greater than 1%. The sensitivity is approximately 0.1% by weight for the samples assayed. Comparison of total % of GPL groups measured was not more than 3% of 31 P-NMR measurements. Additional information available through appropriate calculations could be mol% of each GPL species and mol% of fatty acids based on summation within GPL group or as a total. The reported technique overcomes the problem of isotope correction necessary with non-chromatographic approaches. Analysis time is faster than classical approaches with minimized sample preparation for a single analytical platform that requires 15 minutes per GPL group. The use of commercially available non-endogenous and non-isobaric internal standards for calibration and quantitation minimizes need for molecularly identical standards for all GPLs. This technique is potentially applicable to any source of these GPLs provided due diligence and care is taken in the initial characterization step for each new matrix. Necessity to assay phosphatidic acid and phosphatidylglycerol GPL groups would require some pre-fractionation step such as normal phase HPLC or solid phase extraction or molecular adduction with a volatile metal such as lithium to provide selective assay. 9